1315 Capital and MoonSail Capital Acquire Majority Stake in Homestead Smart Health Plans

Traditions Health Acquires Homestead Hospice

December 1, 2021

Healthcare Services

Traditions Health, a Dorilton-backed national hospice and home health provider, has acquired Homestead Hospice, a Roswell, Georgia–based multi-state hospice operator that runs 26 offices across five states. The add-on strengthens Traditions' southeast footprint—notably in Georgia and South Carolina—and adds a presence in Alabama, expanding Traditions' geographic reach.

Hale Capital Partners Acquires Majority Stake in Athenium

November 6, 2024

Software

Hale Capital Partners, a New York-based growth private equity firm, led a cooperative recapitalization to acquire a majority stake in Athenium, a Dover, New Hampshire provider of risk and quality management software. The investment brings in Jim Greenwell as CEO and will support product development, AI/analytics capabilities and expansion into new verticals including insurance, financial services and government.

Private Investor Acquires Homestead Custom Cabinetry, Inc.

August 8, 2025

Building Products

Homestead Custom Cabinetry, Inc., a handcrafted cabinetry manufacturer headquartered in Akron, Pennsylvania, was sold to a private investor in a transaction that closed August 8, 2025. Generational Group served as the M&A advisor on the deal facilitating the ownership transition.

Homestead Road Acquires Twin Cities Home Buyers

February 8, 2026

Real Estate

Homestead Road, a tech-enabled residential real estate company, has acquired Twin Cities Home Buyers, a local real estate investment firm serving the Twin Cities metro. Twin Cities Home Buyers will continue operating locally under the Homestead Road platform as the company pursues a roll-up strategy to consolidate the fragmented fix-and-flip market; financial terms were not disclosed.

1315 Capital Backs USpharma Ltd. with Growth Equity Investment

June 30, 2025

Pharmaceuticals

USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.

1315 Capital Acquires Biocoat, Inc.

January 16, 2019

Medical Devices

Philadelphia-based healthcare investment firm 1315 Capital has acquired Biocoat, Inc., a Horsham, Pennsylvania specialty manufacturer of hydrophilic biomaterial coatings for medical devices; the transaction closed on December 20, 2018. 1315 Capital's investment will provide expansion and growth capital to accelerate R&D, expand Biocoat's operating model, and support broader commercial efforts across neurovascular, cardiovascular, peripheral, and ophthalmic end markets.